Oura agrees to buy AI primary care startup Counsel Health for $625 million in cash

Oura has agreed to acquire Counsel Health for $625 million in cash, subject to purchase price adjustments. The companies expect the transaction to close before the end of 2026, subject to customary conditions. Their announcement describes an agreement, rather than a completed acquisition.

Counsel combines medical AI with access to physicians. Oura members can begin with an AI conversation and bring in a doctor when needed. TechCrunch dates the Oura app integration to June. The companies plan to expand their partnership across preventive, acute, specialty and chronic care, while Counsel continues serving other enterprise partners.

Counsel announced a $25 million Series A on October 16, 2025, led by Andreessen Horowitz and GV. Its funding announcement also described an earlier $11 million seed round led by Andreessen Horowitz in October 2024. The company said the new funding would support its physician network, AI development and enterprise partnerships.

The acquisition follows Oura's decision to postpone its Nasdaq IPO. Oura attributed that decision to uncertainty in the IPO market and said it could choose when to pursue a listing. The postponement announcement did not give a new offering date.

Alongside the deal, Oura reported revenue of $533 million for the quarter ended September 30, 2026, up 153 percent year over year. It describes those results as preliminary and unaudited.

For makers, the product decision is to connect continuous biometric measurements with a service that can act on a member's concerns. That remains a plan for the combined business, rather than evidence that the acquisition has already improved health outcomes.